Global study marks major treatment advance for tough-to-treat high-risk blood cancer
Results from a new clinical trial led by Wake Forest University School of Medicine and Atrium Health Levine Cancer show that a new therapy could provide significantly better outcomes for patients with high-risk essential ...
Feb 10, 2026
0
9









